Cerament G
Device Bone void and fracture
PDI 07350055430387
General payments
$1,366,880
Research payments
$209,220
Through program year 2025, $1,366,880 in general payments and $209,220 in research payments were reported against Cerament G (Bone void and fracture).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $687,870 | 1,519 |
| 2025 | Research | $96,902 | 25 |
| 2024 | General | $613,319 | 1,376 |
| 2024 | Research | $21,781 | 11 |
| 2023 | Research | $8,658 | 5 |
| 2022 | General | $65,691 | 141 |
| 2022 | Research | $12,902 | 8 |
| 2021 | Research | $68,978 | 34 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 50 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,036 general · 83 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.